Manish Patel on Muck Rack

Manish Patel

Mumbai
As seen in: Amazon Web Services, Medium, Arthritis & Rheumatology, Center for Disease Control and Prevention, Color Research & Application, Nature, Wiley Online Library, Archives of Disease in Childhood, Frontiers, MDPI and
True nature lover, Loves travelling

Get in touch with Manish

Contact Manish, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Manish Patel’s Biography

Read Full Bio →

I’m a passionate, optimistic & dedicated person who takes up responsibilities with utmost enthusiasm and see to it that I complete my tasks and assignments in time. I’ve a great amount of perseverance to achieve my goal. My optimistic and planned approach in things I do is what driving me towards my success.

Articles

What's New in CData Sync 26.2

|
By Manish Patel
| cdata.com
CData Sync 26.2 is our most feature-rich release in recent memory. This version delivers Git-based version control for pipeline configurations, Python scripting in Events, UI-configurable parallel reads for high-volume databases, a fresh visual redesign, a guided application database migration wizard, and a wide range of improvements to Change Data Capture. Here is a full look at what is new and why it matters.
Open in Who Shared Issue with article?

Ravsons Signs Major India Reseller Partnership with SentryBay to Strengthen Endpoint Data Security

|
By Manish Patel
| News by Wire
SentryBay, a global leader in preventative endpoint protection, today announced a reseller partnership with Ravsons, one of India’s fastest-growing cybersecurity solutions providers. The agreement expands the availability of SentryBay’s patented Armored Client technology across the Indian market. This strategic collaboration addresses a growing challenge for enterprises: protecting sensitive data at the endpoint in an era of hybrid work, cloud adoption, and AI-powered cyber threats.
Open in Who Shared Issue with article?

Dr Olawaiye on the Final OS Data From the Phase 3 ROSELLA Trial in Platinum-Resistant Ovarian Cancer

|
By Manish Patel, Alexander B. Olawaiye, Caroline Seymour 
| OncLive
“What I presented [at the 2026 SGO Annual Meeting] is the mature final overall survival data, which is highly statistically significantly positive with a hazard ratio of 0.65.” Alexander Olawaiye, MD, vice chair for DEI and professor in the Department of Obstetrics, Gynecology and Reproductive Sciences, and director of gynecologic cancer research at Magee-Women’s Hospital at the University of Pittsburgh Medical Center, discussed the final overall survival (OS) results from the phase 3 ROSELLA...
Open in Who Shared Issue with article?
See all 264 licensed articles (275 Total)

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Manish

Contact Manish, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified